Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 1.

Area of Science:

• Cardiology
• Heart Failure Research
• Clinical Trial Design

Background:

• Acute decompensated heart failure (ADHF) carries high mortality despite advances.
• Persistent congestion despite diuretic therapy indicates poor prognosis.
• Emerging device-based therapies for ADHF require careful patient selection.

Purpose of the Study:

• To identify patient risk factors for residual congestion in ADHF.
• To summarize evidence for early recognition of high-risk profiles.
• To propose criteria for selecting high-risk patients in future ADHF trials.

Main Methods:

• Review of patient risk factors associated with residual congestion.
• Classification of risk factors: previous clinical course, congestion severity, diuretic response, renal impairment.
• Overview of inclusion criteria in recent ADHF trials and device studies.

Main Results:

• Identified key patient characteristics predicting poor outcomes in ADHF.
• Highlighted the importance of diuretic response and renal function.
• Emphasized the need for refined patient selection in clinical trials.

Conclusions:

• Accurate identification of high-risk ADHF patients is essential for effective treatment.
• Proposed risk stratification criteria can optimize patient selection for novel therapies.
• Future trials should incorporate these criteria to improve therapeutic benefit.